Data / Form D filings / Aspire BioPharma, Inc.
Aspire BioPharma, Inc.: Form D filing
Aspire BioPharma, Inc., a pharmaceuticals company in Humacao, PR, filed a Form D with the SEC in 2023. The latest, on November 1, 2023, reports an offering of $10 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 194 CANDELERO DRIVE, #223, Humacao, PR, 00797
- Phone
- (801) 427-1111
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Puerto Rico
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1995528
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 1, 2023 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ernest scheidemann | Executive Officer, Director | |
| Rodrick Prat | Director | |
| Kraig Higginson | Executive Officer, Director | |
| Stephen Quesenberry | Executive Officer, Director | |
| Edward Kimball | Director |
Other pharmaceuticals companies in Puerto Rico that filed recently
- MBQ PHARMA INC. $991,038 · Aug 14, 2026
Every Form D from the week of Oct 30, 2023 · All recent filings in Puerto Rico · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aspire BioPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.